Bluemtec Co (XKRX:439580) Retained Earnings : ₩9,208 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Bluemtec Co Retained Earnings?

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Bluemtec Co's retained earnings for the quarter that ended in Dec. 2024 was ₩9,208 Mil.

Bluemtec Co's quarterly retained earnings declined from Jun. 2024 (₩14,589 Mil) to Sep. 2024 (₩11,151 Mil) and declined from Sep. 2024 (₩11,151 Mil) to Dec. 2024 (₩9,208 Mil).

Bluemtec Co's annual retained earnings declined from Dec. 2022 (₩-23,648 Mil) to Dec. 2023 (₩-25,990 Mil) but then increased from Dec. 2023 (₩-25,990 Mil) to Dec. 2024 (₩9,208 Mil).

Bluemtec Co Retained Earnings Historical Data

The historical data trend for Bluemtec Co's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bluemtec Co Retained Earnings Chart

Bluemtec Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Retained Earnings

-1,662.73

-9,261.63

-23,648.04

-25,990.17

9,207.76

Bluemtec Co Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Retained Earnings	Get a 7-Day Free Trial								-25,990.17	-27,832.68	14,588.65	11,150.59	9,207.76

Bluemtec Co Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Bluemtec Co (XKRX:439580) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.

Bluemtec Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Bluemtec Co Ltd (XKRX:439580) » Definitions » Retained Earnings

Comparable Companies

Traded in Other Exchanges

N/A

Address

45 Dream Industrial Complex 1-ro, Cheongbuk-eup, Gyeonggi-do, Pyeongtaek-si, KOR

Website

https://www.bluemtec.com

Bluemtec Co Ltd is a company whose main business is selling prescription drugs through an e-commerce platform. It operates two pharmaceutical distribution platforms, BluePharmKorea targeting hospitals and clinics, and KoolPharm targeting pharmacies and provide IT services to operate and advance these two platforms. In addition, it is operating BlueLabs, which provides services and website development for pharmaceutical companies and medical institutions.

Bluemtec Co Headlines

No Headlines